A solid-phase assay for studying direct binding of progranulin to TNFR and progranulin antagonism of TNF/TNFR interactions

Methods in Molecular Biology

Volumn 1155, Issue , 2014, Pages 163-172

  Tian, Qingyun ^a   Zhao, Shuai ^a   Liu, Chuanju ^a  

^a NONE

Author keywords

Biotin labeled protein; Progranulin; Solid phase assay; TNF; TNFR

Indexed keywords

BIOTIN; PROGRANULIN; STREPTAVIDIN; TUMOR NECROSIS FACTOR RECEPTOR; GRANULIN PRECURSOR PROTEIN; IMMOBILIZED PROTEIN; PROTEIN BINDING; RECOMBINANT PROTEIN; SIGNAL PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; BIOTINYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEK293 CELL LINE; HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SOLID; BIOASSAY; CHEMISTRY; DRUG EFFECTS; METABOLISM; PROCEDURES; PROTEIN DOMAIN;

BIOLOGICAL ASSAY; BIOTIN; HUMANS; IMMOBILIZED PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; STREPTAVIDIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84921439612     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0669-7_14     Document Type: Article

References (29)

1. Aroca-Aguilar JD, Sanchez-Sanchez F, Ghosh S, Fernandez-Navarro A, Coca-Prados M, Escribano J (2011) Interaction of recombinant myocilin with the matricellular protein SPARC: functional implications. Invest Ophthalmol Vis Sci 52:179–189
2. Graham NA, Pope MD, Rimchala T, Huang BK, Asthagiri AR (2007) A microtiter assay for quantifying protein-protein interactions associated with cell-cell adhesion. J Biomol Screen 12:683–693
3. Arlinghaus FT, Eble JA (2012) The collagenbinding integrin alpha2beta1 is a novel interaction partner of the T. flavoviridis venom protein flavocetin-A. J Biol Chem 288:947–955
4. Liu CJ (2011) Progranulin: a promising therapeutic target for rheumatoid arthritis. FEBS Lett 585:3675–3680
5. Liu CJ, Bosch X (2012) Progranulin: a growth factor, a novel TNFR ligand and a drug target. Pharmacol Ther 133:124–132
6. Daniel R, He Z, Carmichael KP, Halper J, Bateman A (2000) Cellular localization of gene expression for progranulin. J Histochem Cytochem 48:999–1009
7. Wang D, Bai X, Tian Q, Lai Y, Lin EA, Shi Y et al (2012) GEP constitutes a negative feedback loop with MyoD and acts as a novel mediator in controlling skeletal muscle differentiation. Cell Mol Life Sci 69:1855–1873
8. Matsubara T, Mita A, Minami K, Hosooka T, Kitazawa S, Takahashi K et al (2012) PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue. Cell Metab 15:38–50
9. Elkabets M, Gifford AM, Scheel C, Nilsson B, Reinhardt F, Bray MA et al (2011) Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J Clin Invest 121:784–799
10. He Z, Bateman A (1999) Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo. Cancer Res 59:3222–3229
11. Frampton G, Invernizzi P, Bernuzzi F, Pae HY, Quinn M, Horvat D et al (2012) Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism. Gut 61:268–277
12. Serrero G (2003) Autocrine growth factor revisited: PC-cell-derived growth factor (progranulin), a critical player in breast cancer tumorigenesis. Biochem Biophys Res Commun 308:409–413
13. Diaz-Cueto L, Arechavaleta-Velasco F, Diaz-Arizaga A, Dominguez-Lopez P, Robles-Flores M (2012) PKC signaling is involved in the regulation of progranulin (acrogranin/PC-cellderived growth factor/granulin-epithelin precursor) protein expression in human ovarian cancer cell lines. Int J Gynecol Cancer 22: 945–950
14. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C et al (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442:916–919
15. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D et al (2006) Null mutations in progranulin cause ubiquitinpositive frontotemporal dementia linked to chromosome 17q21. Nature 442:920–924
16. Ghidoni R, Benussi L, Glionna M, Franzoni M, Binetti G (2008) Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology 71:1235–1239
17. Sleegers K, Brouwers N, Van Damme P, Engelborghs S, Gijselinck I, van der Zee J et al (2009) Serum biomarker for progranulinassociated frontotemporal lobar degeneration. Ann Neurol 65:603–609
18. Finch N, Baker M, Crook R, Swanson K, Kuntz K, Surtees R et al (2009) Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 132:583–591
19. Jian J, Konopka J, Liu C (2012) Insights into the role of progranulin in immunity, infection, and inflammation. J Leukoc Biol 93:199–208
20. Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY et al (2011) The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332:478–484
21. Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M et al (2012) B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol 13:170–180
22. Park B, Buti L, Lee S, Matsuwaki T, Spooner E, Brinkmann MM et al (2011) Granulin is a soluble cofactor for toll-like receptor 9 signaling. Immunity 34:505–513
23. Tian QY, Zhao YP, Liu CJ (2012) Modified yeast-two-hybrid system to identify proteins interacting with the growth factor progranulin. J Vis Exp 59:e3562
24. Feng JQ, Guo FJ, Jiang BC, Zhang Y, Frenkel S, Wang DW et al (2010) Granulin epithelin precursor: a bone morphogenic protein 2-inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis. FASEB J 24:1879–1892
25. Songsrirote K, Li Z, Ashford D, Bateman A, Thomas-Oates J (2010) Development and application of mass spectrometric methods for the analysis of progranulin N-glycosylation. J Proteomics 73:1479–1490
26. Gonzalez EM, Mongiat M, Slater SJ, Baffa R, Iozzo RV (2003) A novel interaction between perlecan protein core and progranulin: potential effects on tumor growth. J Biol Chem 278:38113–38116
27. Whitelock JM, Graham LD, Melrose J, Murdoch AD, Iozzo RV, Underwood PA (1999) Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells. Matrix Biol 18:163–178
28. Knox S, Merry C, Stringer S, Melrose J, Whitelock J (2002) Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors. J Biol Chem 277:14657–14665
29. Knox S, Fosang AJ, Last K, Melrose J, Whitelock J (2005) Perlecan from human epithelial cells is a hybrid heparan/chondroitin/ keratan sulfate proteoglycan. FEBS Lett 579: 5019–5023